|
KIAA1279 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.597400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.185000E-01 |
| Normal-vs-Stage2 |
4.008200E-01 |
| Normal-vs-Stage3 |
9.088000E-01 |
| Normal-vs-Stage4 |
2.627000E-01 |
| Stage1-vs-Stage2 |
5.237600E-01 |
| Stage1-vs-Stage3 |
4.859600E-01 |
| Stage1-vs-Stage4 |
1.079780E-01 |
| Stage2-vs-Stage3 |
3.012600E-01 |
| Stage2-vs-Stage4 |
8.789700E-02 |
| Stage3-vs-Stage4 |
3.022800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.128000E-01 |
| Normal-vs-AfricanAmerican |
2.192600E-01 |
| Normal-vs-Asian |
5.265800E-01 |
| Caucasian-vs-AfricanAmerican |
2.164600E-01 |
| Caucasian-vs-Asian |
4.136600E-01 |
| AfricanAmerican-vs-Asian |
1.084630E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.718600E-01 |
| Normal-vs-Female |
7.635800E-01 |
| Male-vs-Female |
8.823600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.308600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.635000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.787800E-01 |
| Normal-vs-Age(81-100Yrs) |
6.284800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.686220E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.421600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.034200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.691400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.597000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.436800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.190400E-01 |
| Classical-VS-Follicular |
9.813200E-01 |
| Classical-VS-Other |
9.191800E-01 |
| Classical-VS-Normal |
6.288200E-01 |
| Tall-VS-Follicular |
9.150000E-01 |
| Tall-VS-Other |
9.711200E-01 |
| Tall-VS-Normal |
7.871000E-01 |
| Follicular-VS-Other |
9.396000E-01 |
| Follicular-VS-Normal |
7.036000E-01 |
| Other-VS-Normal |
9.246400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.208200E-01 |
| Normal-vs-N1 |
1.130980E-01 |
| N0-vs-N1 |
9.926100E-02 |
|
|
